Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2075 of 3173 entries
View as:

A Study To Determine Effects Of Fluticasone Propionate On Sputum Neutrophils After Inhaled Lipopolysaccharide Challenge In Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01364519 Org: User:
Start: 07/31/11 End: 01/31/12 Due: 01/31/13

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00134511 Org: User:
Start: 03/31/05 End: 11/30/05 Due: 11/30/06

Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in Austria

Phase: N/A Priority: Normal
NCT ID: NCT01877239 Org: User:
Start: 12/10/12 End: 06/14/16 Due: 06/14/17

An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00383188 Org: User:
Start: 12/15/06 End: 07/16/08 Due: 07/16/09

A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))

Phase: N/A Priority: Normal
NCT ID: NCT02237729 Org: User:
Start: 09/30/14 End: 03/31/15 Due: 03/31/16

Treatment Resistance Following Anti-cancer Therapies

Phase: N/A Priority: Normal
NCT ID: NCT04436120 Org: User:
Start: 02/13/19 End: 12/14/20 Due: 12/14/21

A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00927823 Org: User:
Start: 12/31/09 End: 04/30/12 Due: 04/30/13

A Study to Learn About Effect of Sisunatovir in Healthy Adult Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05873764 Org: User:
Start: 05/25/22 End: 07/12/22 Due: 07/12/23

A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults

Phase: N/A Priority: Normal
NCT ID: NCT05745701 Org: User:
Start: 02/22/23 End: 05/29/23 Due: 05/29/24

A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Breast-Feeding Women

Phase: N/A Priority: Normal
NCT ID: NCT06453356 Org: User:
Start: 06/10/24 End: 09/26/24 Due: 09/26/25

TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

Phase: N/A Priority: Normal
NCT ID: NCT04413617 Org: User:
Start: 07/29/20 End: 02/07/22 Due: 02/07/23

Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections

Phase: N/A Priority: Normal
NCT ID: NCT01726023 Org: User:
Start: 01/31/13 End: 03/31/15 Due: 03/31/16

Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT03140176 Org: User:
Start: 08/15/17 End: 01/22/22 Due: 01/22/23

Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis

Phase: N/A Priority: Normal
NCT ID: NCT01146561 Org: User:
Start: 10/13/10 End: 03/22/11 Due: 03/22/12

Ibuprofen Sodium Tension Headache Study

Phase: N/A Priority: Normal
NCT ID: NCT01362491 Org: User:
Start: 06/30/11 End: 03/31/12 Due: 03/31/13

To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.

Phase: N/A Priority: Normal
NCT ID: NCT05576051 Org: User:
Start: 06/04/15 End: 10/07/15 Due: 10/07/16

Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT04979988 Org: User:
Start: 08/02/21 End: 12/09/21 Due: 12/09/22

A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1

Phase: N/A Priority: Normal
NCT ID: NCT00823979 Org: User:
Start: 03/25/09 End: 10/18/12 Due: 10/18/13

Global Prevalence of ATTR-CM in Participants With HFpEF

Phase: N/A Priority: Normal
NCT ID: NCT04424914 Org: User:
Start: 12/30/20 End: 06/02/23 Due: 06/02/24

The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00163085 Org: User:
Start: 05/31/05 End: 01/31/06 Due: 01/31/07

Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)

Phase: N/A Priority: Normal
NCT ID: NCT00569946 Org: User:
Start: 12/12/07 End: 10/30/12 Due: 10/30/13

Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT02687191 Org: User:
Start: 11/30/16 End: 01/31/18 Due: 01/31/19

Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT00754221 Org: User:
Start: 05/31/08 End: 05/31/09 Due: 05/31/10

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

Phase: N/A Priority: Normal
NCT ID: NCT05052697 Org: User:
Start: 09/13/21 End: 01/27/23 Due: 01/27/24

Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip

Phase: N/A Priority: Normal
NCT ID: NCT00174317 Org: User:
Start: 08/31/03 End: 02/28/05 Due: 02/28/06